Meng‐Feng Tsai

Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression

Jeremy J.W. Chen, Yi‐Chen Lin, Pei‐Li Yao et al. · Journal of Clinical Oncology · 2004 · 372 citations · Full text

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai et al. · Oncotarget · 2016 · 234 citations · Full text

Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1

Huei‐Wen Chen, Jen‐Yi Lee, Jiying Huang et al. · Cancer Research · 2008 · 219 citations · Full text

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

Jin‐Yuan Shih, Chien‐Hung Gow, Chong‐Jen Yu et al. · International Journal of Cancer · 2005 · 172 citations

ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Cheng-Po Huang, Meng‐Feng Tsai, Tzu‐Hua Chang et al. · Cancer Letters · 2012 · 165 citations

Oncology, Medicine, Receptor Tyrosine Kinase +10